PLWHIV (n=1083) | Controls (n=12 074) | P value* | Never smoking PLWHIV (n=360) | Never smoking controls (n=5717) | P value† | |
FEV1/FVC<LLN, n (%) | 114 (10.6) | 1278 (10.6) | 1.0 | 15 (4.2) | 378 (6.6) | 0.09 |
FEV1≥80% predicted | 29 (25.4) | 747 (58.5) | – | 6 (40.0) | 246 (65.1) | – |
FEV150%–79% predicted | 69 (60.5) | 463 (36.2) | – | 8 (53.3) | 128 (33.9) | – |
FEV130%–49% predicted | 13 (11.4) | 63 (4.9) | – | 1 (6.7) | 3 (0.8) | – |
FEV1<30% predicted | 3 (2.6) | 5 (0.4) | – | 0 (0.0) | 1 (0.3) | – |
FEV1/FVC<0.7 and FEV1predicted <80% | 108 (10.0) | 696 (5.8) | <0.001 | 14 (3.9) | 177 (3.1) | 0.50 |
FEV150%–79% predicted | 92 (85.1) | 625 (89.8) | – | 13 (92.9) | 172 (97.2) | – |
FEV130%–49% predicted | 13 (12.0) | 66 (9.5) | – | 1 (7.1) | 4 (2.2) | – |
FEV1<30% predicted | 3 (2.8) | 5 (0.7) | – | 0 (0.0) | 1 (0.6) | – |
*Comparing PLWHIV with controls.
†Comparing never smoking PLWHIV with never smoking controls.
LLN, lower limit of normal; PLWHIV, people living with HIV.